Arkolith/Insider Trading/CYT/Form 4

Gaiero David G

Chief Financial OfficerCyteir Therapeutics, Inc. (CYT) · full profile →Form 4 · filed Dec 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 11, 2023Option exercise(M)2K$1.68$3K90K
Dec 11, 2023Option exercise(M)2K$1.69$4K92K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2023Option exercise(M)2K—$090K
Dec 11, 2023Option exercise(M)2K—$019K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-058610) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML